» Articles » PMID: 30519584

Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation Without Altering the Autophagy Flux

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Dec 7
PMID 30519584
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Dry eye disease (DED) is a multifactorial ocular surface disorder affecting millions of individuals worldwide. Inflammation has been associated with dry eye and anti-inflammatory drugs are now being targeted as the alternate therapeutic approach for dry eye condition. In this study, we have explored the anti-inflammatory and autophagy modulating effect of chloroquine (CQ) in human corneal epithelial and human corneal fibroblasts cells exposed to desiccation stress, (an model for DED). Gene and protein expression profiling of inflammatory and autophagy related molecular factors were analyzed in HCE-T and primary HCF cells exposed to desiccation stress with and without CQ treatment. HCE-T and HCF cells exposed to desiccation stress exhibited increased levels of activated p65, TNF-, MCP-1, MMP-9, and IL-6. Further, treatment with CQ decreased the levels of active p65, TNF-, MCP-1, and MMP-9 in cells underdesiccation stress. Increased levels of LC3B and LAMP1 markers in HCE-T cells exposed to desiccation stress suggest activation of autophagy and the addition of CQ did not alter these levels. Changes in the phosphorylation levels of MAPKinase and mTOR pathway proteins were found in HCE-T cells under desiccation stress with or without CQ treatment. Taken together, the data suggests that HCE-T cells under desiccation stress showed NFB mediated inflammation, which was rescued through the anti-inflammatory effect of CQ without altering the autophagy flux. Therefore, CQ may be used as an alternate therapeutic management for dry eye condition.

Citing Articles

Shiga Toxins Produced by Enterohaemorrhagic Induce Inflammation in Toxin-Sensitive Cells through the p38 MAPK/MK2/Tristetraprolin Signaling Pathway.

Park S, Jeong Y, Lee K, Park J, Park J, Tesh V J Microbiol Biotechnol. 2024; 34(12):2439-2449.

PMID: 39617691 PMC: 11729694. DOI: 10.4014/jmb.2410.10016.


KCNK5 Regulating Potassium Efflux and Inducing Pyroptosis in Corneal Epithelial Cells Through TNFSF10-Mediated Autophagy in Dry Eye.

Liao K, Zeng H, Yang X, He D, Wang B, Yuan J Invest Ophthalmol Vis Sci. 2024; 65(1):34.

PMID: 38236186 PMC: 10807492. DOI: 10.1167/iovs.65.1.34.


The roles of autophagy and mitophagy in corneal pathology: current knowledge and future perspectives.

Ayilam Ramachandran R, Sanches J, Robertson D Front Med (Lausanne). 2023; 10:1064938.

PMID: 37153108 PMC: 10160402. DOI: 10.3389/fmed.2023.1064938.


Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.

Jeyabalan N, Pillai A, Khamar P, Shetty R, Mohan R, Ghosh A Indian J Ophthalmol. 2023; 71(4):1285-1291.

PMID: 37026260 PMC: 10276742. DOI: 10.4103/IJO.IJO_2912_22.


Development of In Vitro Dry Eye Models to Study Proliferative and Anti-Inflammatory Effects of Allogeneic Serum Eye Drops.

Voss S, Behrmann T, Reichl S Int J Mol Sci. 2023; 24(2).

PMID: 36675083 PMC: 9864688. DOI: 10.3390/ijms24021567.


References
1.
Wu J, Du Y, Mann M, Funderburgh J, Wagner W . Corneal stromal stem cells versus corneal fibroblasts in generating structurally appropriate corneal stromal tissue. Exp Eye Res. 2014; 120:71-81. PMC: 3979324. DOI: 10.1016/j.exer.2014.01.005. View

2.
van den Borne B, Dijkmans B, de Rooij H, le Cessie S, Verweij C . Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol. 1997; 24(1):55-60. View

3.
Strozyk E, Kulms D . The role of AKT/mTOR pathway in stress response to UV-irradiation: implication in skin carcinogenesis by regulation of apoptosis, autophagy and senescence. Int J Mol Sci. 2013; 14(8):15260-85. PMC: 3759859. DOI: 10.3390/ijms140815260. View

4.
Acera A, Rocha G, Vecino E, Lema I, Duran J . Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res. 2008; 40(6):315-21. DOI: 10.1159/000150445. View

5.
Geerling G, MacLennan S, Hartwig D . Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004; 88(11):1467-74. PMC: 1772389. DOI: 10.1136/bjo.2004.044347. View